Aptevo Therapeutics Files 8-K
Ticker: APVO · Form: 8-K · Filed: Jun 30, 2025 · CIK: 1671584
| Field | Detail |
|---|---|
| Company | Aptevo Therapeutics Inc. (APVO) |
| Form Type | 8-K |
| Filed Date | Jun 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, other-events
Related Tickers: APVO
TL;DR
APVO filed an 8-K on 6/30, but no juicy details yet.
AI Summary
Aptevo Therapeutics Inc. filed an 8-K on June 30, 2025, reporting other events. The filing does not contain specific details about the nature of these events, dollar amounts, or new developments beyond the standard reporting requirement.
Why It Matters
This 8-K filing indicates that Aptevo Therapeutics Inc. has made a regulatory submission, but it lacks specific details on the event itself, making its immediate impact unclear.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting 'Other Events' without providing specific material information, thus posing a low immediate risk.
Key Players & Entities
- Aptevo Therapeutics Inc. (company) — Registrant
- June 30, 2025 (date) — Date of Report
FAQ
What specific 'Other Events' are being reported by Aptevo Therapeutics Inc. in this 8-K filing?
The provided filing text does not specify the nature of the 'Other Events' reported by Aptevo Therapeutics Inc. on June 30, 2025.
Does this 8-K filing contain any financial information or updates on Aptevo Therapeutics Inc.'s business operations?
The filing is a standard 8-K for 'Other Events' and does not include specific financial data or operational updates in the provided text.
When was this 8-K filed by Aptevo Therapeutics Inc.?
Aptevo Therapeutics Inc. filed this 8-K on June 30, 2025.
What is the principal executive office address for Aptevo Therapeutics Inc.?
The principal executive offices of Aptevo Therapeutics Inc. are located at 2401 4th Avenue, Suite 1050, Seattle, Washington, 98121.
Is there any indication of material agreements or changes in the company's structure reported in this filing?
The filing is categorized under 'Other Events' and does not explicitly detail material agreements or structural changes in the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding Aptevo Therapeutics Inc. (APVO).